FSTL3-Neutralizing Antibodies Enhance Glucose-Responsive Insulin Secretion in Dysfunctional Male Mouse and Human Islets is a research paper published in Endocrinology (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Small Business Innovation Research and Small Business Technology Transfer
Grant: R44DK107018
National Institute of General Medical Sciences
Grant: R35GM134923
National Institutes of Health
Grant: 5R35GM134923-04
Structural/functional characterization of TGFβ superfamily signaling and regulation
National Institutes of Health
Grant: 2R44DK107018-03A1
Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals